Journal of Clinical Endocrinology & Metabolism, Vol 46, 114-118, Copyright © 1978 by Endocrine Society

ARTICLES

Evidence for an angiotensinogenic mechanism of the hypertension of Cushing's syndrome

TG Dalakos, AN Elias, GH Anderson Jr, DH Streeten and ET Schroeder

The blood pressure response to the angiotensin II analog 1-sar-8-ala- angiotensin II, or saralasin, was studied in five patients with clinical and laboratory evidence of Cushing's syndrome. Plasma renin activity, plasma renin substrate, and plasma renin concentration were measured in all five patients. The renin system and the response to saralasin were measured after furosemide administration. Plasma aldosterone was measured after infusion of 2 liters normal saline. All patients studied showed a hypotensive response to saralasin, the mean BP changing from 163/108 mm Hg to 130/85 mm Hg (P less than 0.02). There was a significant elevation of the plasma renin activity and plasma renin concentration in the patients compared to normal subjects, although plasma renin substrate was not significantly different from normal values. There was normal suppression of plasma aldosterone after the infusion of 0.9% saline. The findings indicate that the hypertension of these patients with Cushing's syndrome was mediated in large part by angiotensin II.

This article has been cited by other articles:

				D. A. Scheuer and A. G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1719 - R1726. [Abstract] [Full Text] [PDF]

				H. Shibata, H. Suzuki, T. Maruyama, and T. Saruta Gene Expression of Angiotensin II Receptor in Blood Cells of Cushing's Syndrome Hypertension, December 1, 1995; 26(6): 1003 - 1010. [Abstract] [Full Text]